Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HS-10542 in Paroxysmal Nocturnal Hemoglobinuria (PNH)
NCT07470762Phase 2Recruiting
- Sponsor
- Hansoh Pharmaceutical Group
- Start
- Feb 2026
- Primary completion
- May 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of HS-10542 in paroxysmal nocturnal hemoglobinuria (PNH), sponsored by Hansoh Pharmaceutical Group. Started Feb 2026; status: recruiting.
02
Drugs
HS-10542
03
Conditions
paroxysmal nocturnal hemoglobinuria (PNH)
Beyond the preview
Go deeper on NCT07470762.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07470762.